Rare tumor of pancreas

Rare tumor of the pancreas (Orphanet code 180824) is a broad classification encompassing a heterogeneous group of uncommon neoplasms arising in the pancreas that do not fall into the more common categories of pancreatic ductal adenocarcinoma or well-characterized pancreatic neuroendocrine tumors. This grouping may include entities such as solid pseudopapillary neoplasms, acinar cell carcinomas, pancreatoblastomas, and other exceptionally rare pancreatic tumors. These tumors primarily affect the gastrointestinal and endocrine systems, depending on the specific tumor type and whether they are functional (hormone-secreting) or non-functional. Clinical presentation varies widely depending on the specific tumor subtype, location within the pancreas, and stage at diagnosis. Common symptoms may include abdominal pain, a palpable abdominal mass, weight loss, nausea, jaundice (if the tumor obstructs the bile duct), and in some cases hormonal syndromes if the tumor produces bioactive substances. Some rare pancreatic tumors, such as solid pseudopapillary neoplasms, tend to occur more frequently in young women and may have a relatively favorable prognosis, while others such as acinar cell carcinoma can be more aggressive. Treatment approaches depend on the specific tumor type, stage, and patient factors. Surgical resection remains the cornerstone of therapy for localized disease and can be curative in many cases. Chemotherapy, radiation therapy, or targeted therapies may be employed for advanced or metastatic disease, though evidence-based protocols are often limited due to the rarity of these conditions. Management is best carried out at specialized centers with expertise in pancreatic pathology and multidisciplinary oncologic care. Given the heterogeneity of this disease group, prognosis varies significantly across subtypes.

Common questions about Rare tumor of pancreas